Are Insiders Too Confident In MetLife, Inc. (MET)?

On November 29, 2019, MetLife, Inc. (NYSE:MET) shares lost 0% or 0 points to close at $49.91 with a thin trading volume of 1.681 million shares. It opened the trading session at $49.74, the shares rose to $49.99 and dropped to $49.62, the range by which the price of stock traded the whole day. The company now has a market cap of $45.9 billion and currently has 919.07 million outstanding shares. MetLife, Inc. (MET) stock has accumulated 7.82 percent of market value in 21 trading days.

MET stock’s trailing 3-year beta is 1.13, meaning there will be a greater rate of return, although posing a higher risk. The part of a firm’s profit given to each outstanding share of regular stock was $7.5 share in the trailing 52 weeks. The stock’s value surged 21.55 percent year to date (YTD) compared to a rise of 10.69 percent in 52 week’s period. The firm’s shares are still trading -2.44 percent below its 1-year high of $51.16 and 32.18 percent up from 52-week low of $37.76. The average consensus ranking on the company is 2.4, on a ranging where 5 is equal to a consensus sell rating. In other words, the mean analyst recommendations are ranking this stock as a sell.

MetLife, Inc. (MET) is most likely going to rise 6.43 percent in the coming 12 months, as per price target approximations compiled by finviz. Nevertheless, they have set the price target at a $63-month high price target. This represents a whopping 26.23 percent increase from the current trading of shares. The 52-week median price target given by the analysts is $55, which means a return possibility of 10.2 percent in comparison with the closing price of the stock of $49.91 on November 29. The lowest price set for the stock is $41 — just above -17.85 percent from MET share price now.

Past records have indicated that shares in MetLife, Inc. declined on 22 different earnings reaction days and we have yet to see whether this trend will play out and remain in place when the company reports upcoming earnings. Investors will get the next hint of MET’s Q4 earnings on February 05. Analysts are predicting revenue to climb 6.3 percent to $16.4B in the financial fourth quarter, while EPS will soar by about 1.48 percent to $1.37 per share. In the last quarter, it earnings of $1.27 per share came worse than the $1.33721, adjusted, expected by Thomson Reuters consensus estimate. Revenue for the quarter was $15.4B, missing the $15.84B analysts had expected. Earnings are seen to rise by 15.3 percent this year, 9.23 percent in the coming year and the trend continues by 6.34 percent every year in the next 5 years.

Let’s take a glimpse at some insider activity at MetLife, Inc. (NYSE:MET) and observe the pattern. The earliest insider trade happened on 02/12/2019. Goulart Steven J parted with a total of 10.29 thousand shares of the firm at average share price of $44.4. The total amount for the sale was set at $456.96 thousand. On completing this exchange, the EVP & Chief Investment Officer account balance was 82.92 thousand shares. The stock grew 12.41 percent from that insider sale. On 02/12/2019, McCallion John D., EVP & CFO, did a sale of 2.67 thousand shares at a price of $44.43 per share. This got rid of 118.58 thousand shares from the insider’s fortune and the stock experienced a 12.33 percent rally in price since the news became public. This exchange saw 17.87 thousand shares get out from the EVP & CFO account.

On 12/17/2018, Director GUTIERREZ CARLOS M recorded a purchase transaction valued at $249.86 thousand. The purchase at $39.04 a share has added 6.4 thousand shares into the insider’s portfolio position. Meanwhile, shares price witnessed 27.84 percent increase since the transaction reporting date. The company insider is left with 23.48 thousand shares remaining in the account. KANDARIAN STEVEN A, who works as Chairman, President & CEO at the company, performed a sale of 42.81 thousand shares in a transaction worth $2.01 million. The disposal recorded on 08/27/2018 was priced at $47.03 per share. The stock price soared 6.12 percent since the transaction. KANDARIAN STEVEN A currently holds a stake of 525.54 thousand in MET stock which is worth $26.23 million after the insider selling.

The stock is lingering around the initial support level of $49.69. After this, the following support is at the zone of $49.47. Up until the time the MET stock hit levels beyond the current one, bulls should have no alarm. In terms of its momentum, the stock’s RSI hit 72.42 on the daily chart, and this may be a cause for concern. In case the price goes below $49.47 level on closing basis, there may be more profit booking with the stock growing weaker. Still, getting to the $50.06 level may cause a pull-back move approaching $50.21 mark.

MetLife, Inc. (MET) shares are trading at a P/E ratio of 6.7 times earnings posted in the trailing 12 months. The industry MET deals with has an average P/E of 9.4. Its P/B ratio is standing at 0.7X compared to the 1 industry average. It is additionally sporting a 0.7 on the Price-to-Sales ratio, compared to the industry’s P/S average of 0.8.